Liver Diseases  >>  MK-7680  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK-7680 / Merck (MSD)
NCT02269059: Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)

Completed
1
13
Europe
MK-7680
Merck Sharp & Dohme LLC
Hepatitis C
02/15
04/15

Download Options